SANOFI-AVENTIS (EPA:SAN) | WebDisclosure

Basculer en Français

9480	Companies
185563	Keywords
117965	Articles
99397	Press releases

Home
Companies
SANOFI-AVENTIS

PRESS RELEASE

published on 08/06/2025 at 07:00, 3 months 30 days ago

Communiqué de presse : Sanofi finalise l’acquisition de Vigil Neuroscience, Inc.
Sanofi finalise l’acquisition de Vigil Neuroscience, Inc. renforçant son pipeline en neurologie avec le VG-3927 pour la maladie d’Alzheimer. Aucun impact sur les prévisions financières 2025

Acquisition Sanofi Neurologie Vigil Neuroscience VG-3927
PRESS RELEASE

published on 08/06/2025 at 07:00, 3 months 30 days ago

Press Release: Sanofi completes the acquisition of Vigil Neuroscience, Inc.
Sanofi announces completion of Vigil Neuroscience, Inc. acquisition, reinforcing neurology pipeline with VG-3927 for Alzheimer's. Vigil shareholders receive CVR. VGL101 not acquired

Acquisition Sanofi Neurology Alzheimer's Vigil Neuroscience
BRIEF

published on 07/22/2025 at 07:35, 4 months 14 days ago

Sanofi acquires Vicebio to boost its respiratory vaccine portfolio

Sanofi Acquisition Vicebio Respiratory Vaccines Molecular Clamp Technology Biotechnology Investment
BRIEF

published on 07/22/2025 at 07:35, 4 months 14 days ago

Sanofi acquiert Vicebio pour booster son portefeuille de vaccins respiratoires

Acquisition Sanofi Vicebio Vaccins Respiratoires Technologie Molecular Clamp Investissement Biotechnologie
PRESS RELEASE

published on 07/22/2025 at 07:30, 4 months 14 days ago

Press Release: Sanofi to acquire Vicebio, expanding respiratory vaccines pipeline
Sanofi acquires Vicebio, enhancing respiratory vaccines pipeline with 'Molecular Clamp' technology and combination vaccine candidates for RSV and hMPV, expanding capabilities in vaccine development

Sanofi Vicebio Respiratory Vaccines Molecular Clamp Technology Combination Vaccines
PRESS RELEASE

published on 07/22/2025 at 07:30, 4 months 14 days ago

Communiqué de presse : Sanofi va acquérir Vicebio et enrichir son pipeline de vaccins respiratoires
Sanofi acquiert Vicebio pour enrichir son pipeline de vaccins respiratoires avec la technologie 'Molecular Clamp'. Accord d'1,15 milliards de dollars. Acquisition renforce l'innovation et le développement de vaccins

Acquisition Sanofi Vicebio Vaccins Respiratoires Molecular Clamp
BRIEF

published on 07/18/2025 at 07:05, 4 months 18 days ago

Sanofi Completes Acquisition of Blueprint Medicines

Acquisition Sanofi Blueprint Medicines Systemic Mastocytosis Ayvakit
BRIEF

published on 07/18/2025 at 07:05, 4 months 18 days ago

Sanofi finalise l'acquisition de Blueprint Medicines

Acquisition Sanofi Médicaments Blueprint Mastocytose Systémique Ayvakit
PRESS RELEASE

published on 07/18/2025 at 07:00, 4 months 18 days ago

Press Release: Sanofi completes acquisition of Blueprint Medicines
Sanofi completes acquisition of Blueprint Medicines, adding rare immunology disease medicines to its portfolio. The acquisition includes Ayvakit/Ayvakyt for systemic mastocytosis (SM) and elenestinib for SM, enhancing Sanofi's immunology pipeline

Acquisition Sanofi Immunology Blueprint Medicines Ayvakit/Ayvakyt
PRESS RELEASE

published on 07/18/2025 at 07:00, 4 months 18 days ago

Communiqué de presse : Sanofi finalise l’acquisition de Blueprint Medicines
Sanofi finalise l’acquisition de Blueprint Medicines, ajoutant des médicaments sur le marché, un pipeline prometteur et l'expertise en mastocytose systémique. Acquisition bénéfique pour Sanofi, sans impact significatif sur les prévisions financières 2025

Acquisition Médicaments Sanofi Blueprint Medicines Mastocytose Systémique

Accesswire

Published on 12/06/2025 at 00:00, 20 minutes ago

Bird River Announces Closing of $0.10 Common Share Financing
Published on 12/05/2025 at 23:30, 50 minutes ago

55 North Mining Inc. Announces Completion of Third and Final Tranche of Private Placement for a Total of $4,202,000
Published on 12/05/2025 at 22:50, 1 hour 30 minutes ago

Banyan Gold Grants Incentive Stock Options
Published on 12/05/2025 at 21:45, 2 hours 35 minutes ago

When the Architecture Becomes Visible: The SMX Revaluation Explained
Published on 12/05/2025 at 21:30, 2 hours 50 minutes ago

The Identity Layer Beneath Everything: Why Markets Are Revaluing SMX All at Once

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 22:15, 2 hours 4 minutes ago

CPI PROPERTY GROUP - Changes in Shareholding and Board of Directors
Published on 12/05/2025 at 22:12, 2 hours 8 minutes ago

EQS-Adhoc: CPI PROPERTY GROUP - Change to Distribution Policy
Published on 12/05/2025 at 18:58, 5 hours 22 minutes ago

EQS-Adhoc: HORNBACH Holding AG & Co. KGaA: Reduced earnings in Q3 2025/26 – Guidance for adjusted EBIT at previous year’s level still valid
Published on 12/05/2025 at 18:26, 5 hours 53 minutes ago

POS-Transaction in Own Shares
Published on 12/05/2025 at 18:15, 6 hours 4 minutes ago

Completion of merger to form Helvetia Baloise Holding Ltd

Les Echos

Published on 12/05/2025 at 23:00, 1 hour 20 minutes ago

ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 12/05/2025 at 23:00, 1 hour 20 minutes ago

ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 12/05/2025 at 23:00, 1 hour 20 minutes ago

ALTAREA : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES NOVEMBRE 2025
Published on 12/05/2025 at 23:00, 1 hour 20 minutes ago

ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES NOVEMBRE 2025
Published on 12/05/2025 at 17:18, 7 hours 2 minutes ago

La vidéo de la réunion de présentation des résultats 2024-2025 du 5 décembre 2025 est disponible

View all LES ECHOS COMFI WIRE